Health TrialsbyHealthPanel

Comparison of the Time to Reach End-Tidal Oxygen Value of 90 and Oxygen Reserve Index Decline Times During Preoxygenation in Sarcopenic and Non-Sarcopenic Patients

ConditionsSarcopeniaPreoxygenationOxygen Reserve Index
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAnkara City Hospital Bilkent

About this trial

The purpose of this study is to compare the time required to reach an end-tidal oxygen (EtO2) value of 90% and the time until the Oxygen Reserve Index (ORI) drops below 0.55 during preoxygenation in sarcopenic and non-sarcopenic patients. The study aims to investigate the impact of sarcopenia on the oxygenation process.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients who agree to participate in the study.

Patients scheduled for major abdominal oncologic surgery.

Disqualifiers

Patients with severe cardiopulmonary disease.

Patients with walking disabilities.

Trial population

80 patients who agreed to participate in the study and are scheduled for major abdominal oncological surgery will be included in the study.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • preoxygenation

    Diagnostic test

    The time required to reach EtO2 90% and the time until ORI drops below 0.55

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: sarcopenic1 intervention
Group B: non-sarcopenic1 intervention

Trial outcomes

Primary outcomes

1

Time required to reach EtO2 90%

Time frame
preoperatively
2

Time until ORI drops below 0.55

Time frame
preoperatively

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ankara City Hospital Bilkent

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: